Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents	$ 78,410	$ 110,643
Restricted cash	1,795	1,804
Investments	193,617	278,344
Trade receivables	68,759	56,950
Inventory, net	4,450	28,683
Prepaid expenses and other current assets	16,426	19,542
Total current assets	363,457	495,966
Long-term inventory, net	24,525	0
Property and equipment, net	7,663	7,910
Long-term investments	64,317	0
Other assets	12,457	13,084
Total assets	472,419	516,960
Liabilities and Stockholders’ Deficit
Accounts payable	7,786	20,893
Accrued expenses	89,598	102,882
Operating lease liabilities	1,026	1,058
Finance lease liabilities	1,681	1,590
Royalty financing obligations	28,974	23,565
Total current liabilities	129,065	149,988
Operating lease liabilities	8,362	8,390
Finance lease liabilities	2,117	2,845
Royalty financing obligations	494,659	508,034
Secured term loan	313,822	303,231
Stockholders’ deficit:
Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding at June 30, 2024 and December 31, 2023	0	0
Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 206,629 at June 30, 2024 and 205,771 at December 31, 2023	2,066	2,058
Additional paid-in capital	1,250,983	1,222,236
Accumulated other comprehensive income	557	1,337
Accumulated deficit	(1,729,212)	(1,681,159)
Total stockholders’ deficit	(475,606)	(455,528)
Total liabilities and stockholders’ deficit	$ 472,419	$ 516,960